Global Narcolepsy Market Expected to reach US$ 4,537.9 Mn in 2027 grow with a CAGR of 9.5%

Sodium Oxybate segment is expected to drive the growth of the global narcolepsy market by application

According to a new market research study titled 'Narcolepsy Market - Global Analysis and Forecasts by Type, Product and Distribution Channel. The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The report highlights the trends prevalent in the global narcolepsy market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to due to increasing healthcare expenditures, increasing prevalence of sleep related neurological disorders and emerging local pharmaceutical and biopharmaceutical companies.

Get Sample Copy at https://www.premiummarketinsights.com/sample/TIP00009535?source-OP-HM

Early buyers will receive 10% customization on reports.

Global narcolepsy market, based on the product was segmented into sodium oxybate, central nervous system (CNS) stimulants, and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.

Some of the prominent players operating in narcolepsy market are Bioprojet, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Inc., Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., Shire (Acquired by Takeda), Ligand Pharmaceuticals, Inc., Novartis AG, Mylan N.V., and Shionogi Inc. The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in October, 2018, Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness in pediatric patients aged 7 to 17 years with narcolepsy. The drug had previously been approved for use in adult patients. The developments performed by the companies are helping the market to grow in the coming years.

Global Narcolepsy Market, By Regions, 2018 (%)

Inquire Before Buying at https://www.premiummarketinsights.com/inquiry/TIP00009535?source-OP-HM


The report segments the global narcolepsy market as follows:

Global Narcolepsy Market - By Type
• Narcolepsy with Cataplexy
• Narcolepsy without Cataplexy
• Secondary Cataplexy

Global Narcolepsy Market - By Product
• Sodium Oxybate
• Central Nervous System (CNS) Stimulants
• Antidepressants

Global Narcolepsy Market - By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies

Global Narcolepsy Market - By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
• Asia Pacific (APAC)
o Japan
o China
o India
o Australia
o South Korea
• Middle East & Africa (MEA)
o South Africa
o UAE
o Saudi Arabia
• South & Central America (SCAM)
o Brazil
o Argentina

Contact Us:
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Pune, India

This release was published on openPR.